Inventor · disambiguated record
Jaebong Jang
Also filed as: JANG JAEBONG
18 granted patents·18 pending applications·27 citations·filing 2015–2024
89Inventor score
Top patents by PatentIndex Score
36 records- 0193US9696040B2Display device and cooking appliance having the sameLG ELECTRONICS INC·Filed 2015·Granted Jul 4, 2017·16 cites·15 claims
- 0286US10450310B2Bifunctional molecules for degradation of EGFR and methods of useDANA FARBER CANCER INST INC·Filed 2018·Granted Oct 22, 2019·5 cites·18 claims
- 0382US12331037B2Pyrimidines as EGFR-inhibitors and methods of treating disordersDANA FARBER CANCER INST INC·Filed 2023·Granted Jun 17, 2025·0 cites·16 claims
- 0480US10266517B2Pyrimidines as EGFR inhibitors and methods of treating disordersDANA FARBER CANCER INST INC·Filed 2015·Granted Apr 23, 2019·2 cites·18 claims
- 0579US10836722B2Inhibitors of EGFR and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Granted Nov 17, 2020·1 cites·18 claims
- 0678US10385019B2Inhibitors of EGFR and methods of use thereofDANA FARBER CANCER INST INC·Filed 2016·Granted Aug 20, 2019·2 cites·21 claims
- 0771US11673882B2Pyrimidines as EGFR inhibitors and methods of treating disordersDANA FARBER CANCER INST INC·Filed 2020·Granted Jun 13, 2023·0 cites·16 claims
- 0868US2022017510A1Bifunctional molecules for degradation of egfr and methods of useDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 0967US11161842B2Bifunctional molecules for degradation of EGFR and methods of useDANA FARBER CANCER INST INC·Filed 2019·Granted Nov 2, 2021·0 cites·19 claims
- 1066US2021094913A1Inhibitors of egfr and methods of use thereofDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 1164US10870636B2Pyrimidines as EGFR inhibitors and methods of treating disordersDANA FARBER CANCER INST INC·Filed 2019·Granted Dec 22, 2020·0 cites·18 claims
- 1263US11945816B2Inhibitors of EGFR and/or HER2 and methods of useDANA FARBER CANCER INST INC·Filed 2021·Granted Apr 2, 2024·0 cites·16 claims
- 1362US10208963B2Cooking applianceLG ELECTRONICS INC·Filed 2016·Granted Feb 19, 2019·1 cites·22 claims
- 1458US2022221158A1Cooking applianceLG ELECTRONICS INC·Filed 2022·Application pending·0 cites
- 1556US11841144B2Cooking applianceLG ELECTRONICS INC·Filed 2021·Granted Dec 12, 2023·0 cites·18 claims
- 1656US2025075967A1Doors for home appliance and home appliance including the sameLG ELECTRONICS INC·Filed 2024·Application pending·0 cites
- 1755US11186574B2Inhibitors of EGFR and/or HER2 and methods of useDANA FARBER CANCER INST INC·Filed 2018·Granted Nov 30, 2021·0 cites·20 claims
- 1855US2025129945A1Home applianceLG ELECTRONICS INC·Filed 2024·Application pending·0 cites
- 1954US2025080817A1Doors for home appliance and home appliance including the sameLG ELECTRONICS INC·Filed 2024·Application pending·0 cites
- 2054US2025080816A1Doors for home appliance and home appliance including the sameLG ELECTRONICS INC·Filed 2024·Application pending·0 cites
- 2154US2025075916A1Doors for home appliance and home appliance including the sameLG ELECTRONICS INC·Filed 2024·Application pending·0 cites
- 2251US12161649B2Inhibitors of EGFR and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Granted Dec 10, 2024·0 cites·22 claims
- 2348US2021230101A1Compounds for treating dengue virus infections and other infectionsDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 2448US2020377501A1Degraders of egfr and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 2547US11814379B2Cyano quinoline amide compounds as HER2 inhibitors and methods of useDANA FARBER CANCER INST INC·Filed 2019·Granted Nov 14, 2023·0 cites·19 claims
- 2646US10145564B2Cooking applianceLG ELECTRONICS INC·Filed 2015·Granted Dec 4, 2018·0 cites·19 claims
- 2746US2020360381A1Compounds for treating dengue virus infection and other viral infectionsDANA FARBER CANCER INST INC·Filed 2018·Application pending·0 cites
- 2843US11584746B2Inhibitors of EGFR and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Granted Feb 21, 2023·0 cites·22 claims
- 2943US10550112B2Pyrimidines as EGFR inhibitors and methods of treating disordersDANA FARBER CANCER INST INC·Filed 2016·Granted Feb 4, 2020·0 cites·25 claims
- 3043US2021085688A1Pharmaceutical combinations of egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 3142US2020375999A1Pharmaceutical combinations of egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 3242US2021077469A1Pharmaceutical combinations of egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 3341US2020390783A1Inhibitors of egfr and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 3441US2020377477A1Degraders of egfr and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 3538US2019016703A1Bifunctional compounds for her3 degradation and methods of useDANA FARBER CANCER INST INC·Filed 2016·Application pending·0 cites
- 3637US2020216454A1Bifunctional molecules for her3 degradation and methods of useDANA FARBER CANCER INST INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jaebong Jang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →